Skip to main content
. Author manuscript; available in PMC: 2017 Aug 8.
Published in final edited form as: Cancer. 2016 Nov 14;123(6):1011–1017. doi: 10.1002/cncr.30445

Table 1.

Baseline patient characteristics (n = 30).

Variable N (%)
Median age (years) 63 (33, 78)
ECOG Performance Status 0 7 (23.3)
1 20 (66.7)
2 3 (10.0)
Grade Moderate 12 (40.0)
Poor 18 (60.0)
Mucinous features None 25 (83.3)
Present 5 (16.7)
History of inflammatory bowel disease No 29 (96.7)
Yes 1 (3.3)
History of Lynch Syndrome No 19 (63.3)
Unknown 11 (36.7)
Race African American 3 (10.0)
Asian 1 (3.3)
Hispanic 4 (13.3)
White 22 (73.3)
Gender Female 17 (56.7)
Male 13 (43.3)
Location Ampulla 7 (23.3)
Small bowel 23 (76.7)
Liver metastases No 13 (43.3)
Yes 17 (56.7)
Peritoneal metastases No 22 (73.3)
Yes 8 (26.7)